{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:24:55Z","timestamp":1777922695272,"version":"3.51.4"},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":8852,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1988,5]]},"abstract":"<jats:p>1. We have previously shown that salbutamol induced hypokalaemia, like adrenaline induced hypokalaemia, is the result of stimulation of a membrane bound beta 2\u2010adrenoreceptor linked to Na+\/K+ ATPase. We have also demonstrated that adrenaline induced hypokalaemia is potentiated by therapeutic concentrations of theophylline. 2. In a single\u2010blind study of 14 normal volunteers, we infused salbutamol in doses used in clinical practice and examined the effects of the addition of theophylline alone or combined with (\u2010)\u2010adrenaline on plasma potassium levels, heart rate and blood pressure. The combinations studied were (i) salbutamol + vehicle control adrenaline infusion + placebo theophylline; (ii) salbutamol + vehicle control adrenaline infusion + theophylline; (iii) salbutamol + adrenaline + theophylline. 3. In a randomised, balanced placebo controlled design oral slow release theophylline or placebo was given for 9 days. Subjects were studied twice on the active limb (days 7 and 9) and once on the placebo limb (day 9) and the procedure was identical on each of the 3 study days except for the solutions administered. 4. Theophylline increased salbutamol induced hypokalaemia and in some individuals profound hypokalaemia (less than 2.5 mmol l\u20101) was observed with these relatively low doses of salbutamol and theophylline. Adrenaline did not further increase the magnitude of the fall in potassium observed. Combining theophylline with salbutamol increased the tachycardia resulting from the salbutamol infusion. Salbutamol infusion caused a fall in diastolic and rise in systolic blood pressure on all 3 study days and this was not altered by either theophylline or adrenaline alone or together.(ABSTRACT TRUNCATED AT 250 WORDS)<\/jats:p>","DOI":"10.1111\/j.1365-2125.1988.tb03347.x","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T23:42:21Z","timestamp":1343346141000},"page":"571-578","source":"Crossref","is-referenced-by-count":30,"title":["Salbutamol induced hypokalaemia: the effect of theophylline alone and in combination with adrenaline."],"prefix":"10.1111","volume":"25","author":[{"given":"KF","family":"Whyte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GJ","family":"Addis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Whitesmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JL","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"49","volume-title":"A.B.P.I. Data Sheet Compendium","year":"1985"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.36.6.435"},{"key":"e_1_2_1_4_1","volume-title":"Data analysis in Rummage: a user guide","author":"Bryce G. R.","year":"1980"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500073-00016"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1934.sp003190"},{"key":"e_1_2_1_7_1","first-page":"44P","article-title":"Regulation of skeletal muscle \u03b2\u2010adrenoceptors in vivo by chronic administration of adrenoceptor agonists and propranolol","volume":"90","author":"Elfellah M. S.","year":"1987","journal-title":"Br. J. Pharmac."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600690420"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.62.5.527"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(85)80111-0"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.290.6464.267"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-0590(81)80025-5"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1983.127.5.609"},{"key":"e_1_2_1_14_1","first-page":"277","article-title":"Evolution of the mechanism of action of methylxanthines: from calcium mobilizers to antagonists of adenosine receptors","volume":"24","author":"Rall T. W.","year":"1982","journal-title":"Pharmacologist"},{"key":"e_1_2_1_15_1","first-page":"269","article-title":"The potentiation of cardiac inotropic responses to norepinephrine by theophylline","volume":"139","author":"Rall T. W.","year":"1963","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb05221.x"},{"key":"e_1_2_1_17_1","first-page":"19","article-title":"A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist\u2010mediated down\u2010regulation of rat renal cortical beta1\u2010 and beta2\u2010adrenergic receptors","volume":"21","author":"Snaveley M. D.","year":"1985","journal-title":"Mol. Pharmac."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0660377"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975175585"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03010.x"},{"key":"e_1_2_1_21_1","first-page":"221","article-title":"Failure of chronic theophylline therapy to alter circulating catecholamine","volume":"70","author":"Whyte K. F.","year":"1987","journal-title":"Eur. J. resp. Dis."},{"key":"e_1_2_1_22_1","first-page":"549","volume-title":"Statistical principles in experimental design","author":"Winer B. J.","year":"1971"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.35.11.823"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1988.tb03347.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1988.tb03347.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1988.tb03347.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T06:14:16Z","timestamp":1693808056000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1988.tb03347.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1988,5]]}},"alternative-id":["10.1111\/j.1365-2125.1988.tb03347.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1988.tb03347.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,5]]}}}